Analytica Presents PeriCoach Real-World Data on Eight-Week Challenge and the Effect of Clinician Engagement2 October 2019
Analytica would like to update our shareholders on a recent presentation of PeriCoach data to the American Urogynecologic Society / International Urogynaecolocical Association (AUGS/IUGA 2019) meeting in Nashville, Tennessee on Saturday 28 September.
Analytica Broker Presentation9 September 2015
Analytica presents an updated investor briefing to be presented to brokers and investors today by Company Chairman Dr Michael Monsour and Non-Executive Director Carl Stubbings.
Investor Presentation5 June 2015
Analytica Ltd presents an updated investor briefing being presented to brokers and institutions over the next few weeks.
Capital Raising announcement and Investor Presentation3 October 2014
Analytica is pleased to announce that it is undertaking an equity capital raising to raise approximately $4.01 million (before offer costs) in conjunction with Lead Manager, Patersons Securities Limited.
Investor Presentation13 February 2014
Analytica Ltd presents an updated investor brief for a number of stockbroking organisations and other potential investors over the next few weeks.
Investor Presentations26 November 2013
Analytica Ltd presents the attached investor brief to be presented to a number of stockbroking organisations in Melbourne, Brisbane, Sydney and other locations over the next few weeks.
Investor Presentation24 October 2013
Analytica presents the attached updated presentation made to stockbrokers in Perth today.
Investor Presentation27 September 2013
Analytica discloses the presentation made to the SPP underwriters on 25 Sept 2013
Investor Information Presentation Slides12 August 2013
Slides used in the Investor Information Presentations Aug 12-14.
Investor Presentations in Brisbane, Sydney and Sunshine Coast30 July 2013
Analytica is pleased to announce a series of investor presentations to be held in Brisbane, Sydney and the Sunshine Coast in mid-August. Download the announcement for further details.